Physicians significantly underestimated the proportion of patients with systemic sclerosis who experienced pain, with rates of 43.4% vs 96.0%.

Researchers evaluated the impact of upadacitinib on early pain control among patients with axial spondyloarthritis.

A systematic review and meta-analysis explored the efficacy of PRP injections for chronic tendinopathy in patients who have failed conservative treatment.